Through its function of degrading the LDLR, PCSK9 is a key player in lipid metabolism by regulating the LDL level in blood responsible for hypercholesterolemia, which is associated with the risk of atherosclerosis (21). This evidence concerns the gene LDLR and atherosclerosis.